AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tabsuglip M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Capsutab Drugs Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Tabsuglip M 500mg/50mg Tablet

Glucovance 500mg/50mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps mitigate severe diabetic complications like nephropathy and vision loss, potentially lowering heart attack and stroke risk. Glucovance may be prescribed independently or alongside other antidiabetic therapies. Optimal effectiveness requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and concurrent medications. Ingesting with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; cessation should only occur under physician guidance. This medication actively controls blood sugar, preventing future complications. Continued adherence to your prescribed diet and exercise regimen is crucial for diabetes management; lifestyle significantly impacts control. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect when combined with insulin or sulfonylureas; learn to identify and treat it. This medication isn't suitable for all individuals. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating women should seek medical counsel before use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be avoided due to its hypoglycemic effects. Your physician will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of Tabsuglip M 500mg/50mg Tablet

The provided text is "undefined," which has no meaning and therefore cannot be rephrased.

Uses of Tabsuglip M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Tabsuglip M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tabsuglip M 500mg/50mg tablets should be administered with a meal.

Common Side effects of Tabsuglip M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Tabsuglip M 500mg/50mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Tabsuglip M 500mg/50mg Tablet with a meal.

How Tabsuglip M 500mg/50mg Tablet works:

Metformin/glimepiride 500mg/50mg tablets combine two diabetes medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Tabsuglip M 500mg/50mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tabsuglip M 500mg/50mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Suglip M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Tabsuglip M 500mg/50mg tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Tabsuglip M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical consultation is recommended.

What if you forget to take Tabsuglip M 500mg/50mg Tablet :

Should you forget a dose of Tabsuglip M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tabsuglip M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Tabsuglip M 500mg/50mg Tablet

Tabsuglip M 500mg/50mg Tablets rarely cause hypoglycemia by themselves, but it can occur if calorie intake is inadequate. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Tabsuglip M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Patients with allergies to Tabsuglip M 500mg/50mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Tabsuglip M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Tabsuglip M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue use and seek immediate medical attention.
Prolonged use of Tabsuglip M 500mg/50mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Tabsuglip M 500mg/50mg Tablet as directed by your doctor is safe. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Tabsuglip M 500mg/50mg Ta...
267
MRP 325
17% off